Alumis Inc (ALMS) – $3.01 Autonomix Medical (AMIX) – $1.20 American Woodmark Corporation (AMWD) – $50.27 Apogee Enterprises (APOG) – $37.58 Is it safe to buy US stocks that are at their 52-week highs?

Financial advisory services for the merger were provided by Morgan Stanley (NYSE: MS) & Co. LLC and Guggenheim Securities, LLC, with legal counsel from Cooley LLP, Fenwick & West LLP, and Paul ...

Financial advisory services for the merger were provided by Morgan Stanley & Co. LLC and Guggenheim Securities, LLC, with legal counsel from Cooley LLP, Fenwick & West LLP, and Paul Hastings LLP. In ...

On Tuesday, Guggenheim resumed coverage on Alumis Inc (NASDAQ: ALMS) by issuing a Buy rating and setting a price target of $18.00, representing significant upside from the current trading price of ...

Alumis has reached significant milestones recently, including the release of 52-week Phase II Open-Label Extension (OLE) data for ESK-001, an oral TYK2 inhibitor used in the treatment of psoriasis.